RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: traumatic brain injury
Accession: DOID:0081292
browse the term
Definition: A brain disease that is characterized by brain dysfunction caused by an outside force, usually a violent blow to the head. (DO)
Synonyms: exact_synonym: Brain Trauma; TBI (Traumatic Brain Injuries); TBI (Traumatic Brain Injury); TBIs (Traumatic Brain Injuries); Traumatic Brain Injuries; Traumatic Encephalopathies; brain traumas; traumatic encephalopathy
primary_id: MESH:D000070642
alt_id: DOID:9003061
GViewer not supported for the selected species.
G
ADAM10
ADAM metallopeptidase domain 10
ISO
RGD
PMID:22489706
RGD:13703033
NCBI chr26:24,768,827...24,921,169
Ensembl chr26:24,768,915...24,919,009
G
APP
amyloid beta precursor protein
treatment
ISO
RGD
PMID:29320530
RGD:13782048
NCBI chr 2:66,037,224...66,320,860
Ensembl chr 2:66,037,261...66,321,306
G
BAD
BCL2 associated agonist of cell death
treatment
ISO
RGD
PMID:24582457
RGD:13782254
NCBI chr 1:9,949,717...9,964,433
Ensembl chr 1:9,949,762...9,964,432
G
CAPN1
calpain 1
ISO
protein:increased expression:cytosol, plasma membrane
RGD
PMID:9469158
RGD:13792664
NCBI chr 1:9,014,087...9,050,389
Ensembl chr 1:9,014,084...9,049,804
G
CAPN2
calpain 2
ISO
RGD
PMID:9469158
RGD:13792664
NCBI chr25:5,845,873...5,905,464
Ensembl chr25:5,846,298...5,905,402
G
CASP3
caspase 3
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125
RGD:329961568
NCBI chr 7:130,589,592...130,610,845
Ensembl chr 7:130,591,166...130,610,899
G
CD163
CD163 molecule
ISO
protein:increased expression:brain, macrophage (rat)
RGD
PMID:22583855
RGD:127285798
NCBI chr11:7,501,562...7,536,332
Ensembl chr11:7,501,150...7,536,295
G
CD8A
CD8 subunit alpha
ISO
mRNA:increased expression:brain (mouse)
RGD
PMID:31383034
RGD:124715446
NCBI chr14:18,878,013...18,885,183
Ensembl chr14:18,878,622...18,883,885
G
CIT
citron rho-interacting serine/threonine kinase
ISO
mRNA:decreased expression:cerebral cortex��(rat)
RGD
PMID:12503083
RGD:2317873
NCBI chr11:115,026,809...115,220,558
Ensembl chr11:115,025,045...115,219,356
G
CXCL10
C-X-C motif chemokine ligand 10
treatment
ISO
RGD
PMID:26435412
RGD:27095897
NCBI chr 7:24,526,657...24,529,193
Ensembl chr 7:24,526,680...24,529,130
G
CXCL12
C-X-C motif chemokine ligand 12
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125
RGD:329961568
NCBI chr 9:40,005,580...40,020,513
Ensembl chr 9:40,011,439...40,020,494
G
CYP2D6
cytochrome P450 family 2 subfamily D member 6
treatment
ISO
RGD
PMID:26068867
RGD:401901590
NCBI chr19:24,667,207...24,672,580
Ensembl chr19:24,667,282...24,671,513
G
DRD1
dopamine receptor D1
treatment
ISO
RGD
PMID:24047867
RGD:13506948
NCBI chr23:77,587,340...77,591,434
G
DRD2
dopamine receptor D2
treatment
ISO
RGD
PMID:24047867
RGD:13506948
NCBI chr 1:104,774,632...104,843,417
Ensembl chr 1:104,774,180...104,842,736
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
ISO
mRNA:decreased expression:cerebral cortex
RGD
PMID:31992337
RGD:329901857
NCBI chr 5:39,487,304...39,900,238
Ensembl chr 5:39,487,418...39,725,747
G
FUBP1
far upstream element binding protein 1
ISO
RGD
PMID:23797733
RGD:13673879
NCBI chr20:55,194,681...55,233,666
Ensembl chr20:55,194,743...55,230,277
G
GNAL
G protein subunit alpha L
ISO
RGD
PMID:29215295
RGD:13513923
NCBI chr18:69,508,254...69,699,628
Ensembl chr18:69,510,512...69,635,000
G
GRIA1
glutamate ionotropic receptor AMPA type subunit 1
ISO
protein:increased phosphorylation:central amygdaloid nucleus (rat)
RGD
PMID:30638118
RGD:405101698
NCBI chr23:55,944,128...56,265,748
Ensembl chr23:56,101,294...56,265,849
G
ICAM1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
G
IL1B
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
G
ITGB1
integrin subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr 9:32,201,030...32,258,247
Ensembl chr 9:32,202,204...32,258,154
G
LAMA1
laminin subunit alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr18:65,996,233...66,162,510
G
LAMP2
lysosomal associated membrane protein 2
ISO
protein:increased expression:hippocampus:
RGD
PMID:28365875
RGD:13703062
G
LCN2
lipocalin 2
ISO
RGD
PMID:31539545
RGD:126781751
NCBI chr12:9,976,278...9,981,087
Ensembl chr12:9,976,614...9,980,870
G
LOC103244924
cyclin-G1
treatment
ISO
RGD
PMID:18612315 PMID:24398934
RGD:151356934 RGD:151356935
NCBI chr23:65,709,759...65,716,913
Ensembl chr23:65,709,786...65,714,711
G
MAPT
microtubule associated protein tau
treatment
ISO
RGD
PMID:25771151 PMID:26484783 PMID:26729399 PMID:28412141
RGD:13800902 RGD:13800909 RGD:13800912 RGD:13800917
NCBI chr16:59,894,400...60,020,723
Ensembl chr16:59,890,221...59,955,612
G
METTL14
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit
ISO
mRNA:decreased expression:cerebral cortex
RGD
PMID:31992337
RGD:329901857
NCBI chr 7:66,169,080...66,195,324
Ensembl chr 7:66,168,855...66,194,121
G
MMP2
matrix metallopeptidase 2
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125
RGD:329961568
NCBI chr 5:41,264,382...41,291,657
Ensembl chr 5:41,264,354...41,291,004
G
MMP9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
G
MPO
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr16:35,120,194...35,130,851
Ensembl chr16:35,120,581...35,130,671
G
NCSTN
nicastrin
ISO
RGD
PMID:18240300
RGD:13801189
NCBI chr20:3,590,044...3,606,205
Ensembl chr20:3,590,725...3,606,066
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
protein:increased expression:brain:
RGD
PMID:30855558
RGD:26884463
NCBI chr10:62,789,647...62,825,651
Ensembl chr10:62,790,124...62,825,339
G
NGF
nerve growth factor
treatment
ISO
RGD
PMID:26285082
RGD:402463964
NCBI chr20:18,361,795...18,413,987
Ensembl chr20:18,413,108...18,413,833
G
NMNAT1
nicotinamide nucleotide adenylyltransferase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27822499
NCBI chr20:121,790,836...121,797,043
G
NOS2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
G
NOX1
NADPH oxidase 1
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125
RGD:329961568
NCBI chr X:89,182,636...89,210,176
Ensembl chr X:89,183,264...89,209,298
G
OCLN
occludin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr 4:65,581,943...65,641,516
Ensembl chr 4:65,582,460...65,644,787
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829224 PMID:28642177
NCBI chr25:3,350,798...3,405,040
G
PDE10A
phosphodiesterase 10A
ISO
RGD
PMID:29215295
RGD:13513923
NCBI chr13:93,012,027...93,684,349
Ensembl chr13:93,020,696...93,344,369
G
PDYN
prodynorphin
ISO
mRNA:increased expression:hippocampus
RGD
PMID:12626770
RGD:633616
NCBI chr 2:54,535,516...54,551,085
Ensembl chr 2:54,535,240...54,551,104
G
PHACTR1
phosphatase and actin regulator 1
treatment
ISO
RGD
PMID:36571365
RGD:401901253
NCBI chr17:58,859,456...59,440,969
Ensembl chr17:58,862,828...59,133,298
G
PPP3R1
protein phosphatase 3 regulatory subunit B, alpha
ISO
RGD
PMID:20713027
RGD:13830881
NCBI chr14:38,832,976...38,907,425
Ensembl chr14:38,832,809...38,905,321
G
PPP3R2
protein phosphatase 3 regulatory subunit B, beta
ISO
RGD
PMID:20713027
RGD:13830881
NCBI chr12:37,838,156...37,841,477
G
PSEN1
presenilin 1
ISO
RGD
PMID:18240300
RGD:13801189
NCBI chr24:50,394,310...50,476,521
Ensembl chr24:50,405,590...50,472,132
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr25:42,733,535...42,742,463
Ensembl chr25:42,734,771...42,742,429
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593 PMID:28642177
NCBI chr 1:8,576,059...8,585,561
Ensembl chr 1:8,576,542...8,586,516
G
TGFB1
transforming growth factor beta 1
treatment
ISO
RGD
PMID:28433746
RGD:14995478
NCBI chr 6:35,651,583...35,674,387
Ensembl chr 6:35,648,677...35,674,365
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
G
TP53
tumor protein p53
treatment
ISO
RGD
PMID:27553877
RGD:14995939
NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223
G
UBE4B
ubiquitination factor E4B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27822499
NCBI chr20:121,597,775...121,744,986
G
DRD2
dopamine receptor D2
ISO
RGD
PMID:26448536
RGD:13506960
NCBI chr 1:104,774,632...104,843,417
Ensembl chr 1:104,774,180...104,842,736
G
DRD3
dopamine receptor D3
ISO
RGD
PMID:26448536
RGD:13506960
NCBI chr22:66,683,987...66,737,645
Ensembl chr22:66,691,177...66,736,690
G
DRD4
dopamine receptor D4
ISO
RGD
PMID:26448536
RGD:13506960
NCBI chr 1:454,018...459,582
G
IL6
interleukin 6
treatment
ISO
RGD
PMID:27113205
RGD:11062140
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:28140659
RGD:13782305
NCBI chr 7:130,589,592...130,610,845
Ensembl chr 7:130,591,166...130,610,899
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:28140659
RGD:13782305
NCBI chr10:86,888,654...86,944,159
Ensembl chr10:86,916,527...86,943,829
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all